Clinical

The future of TAEUS™

TAEUS will initially focus on tissue composition, quantifying fat in the liver to help clinicians identify a pervasive and costly disease.

But TAEUS’ potential reaches far beyond just a single application.

In the future, we believe that TAEUS will visualize tissue temperature and function, helping guide procedures that treat conditions such as cancer and atrial fibrillation, or help identify arterial plaque and internal bleeding.

Tissue
composition

For fatty liver

Quantify fat vs. lean tissue to detect Non-Alcoholic Fatty Liver Disease (NAFLD).

Learn More >

Tissue
temperature

Coming soon

Display tissue temperature in real time, facilitating more precise application of heat or cold during energy-based surgery.

Learn More >

Vascular
imaging

Coming soon

View blood vessels from any angle, unlike Doppler ultrasound, making it easier to identify arterial plaque or malformed vessels.

Tissue
perfusion

Coming soon

Image blood flow at the capillary level in a region, organ or tissue—helping to identify damaged tissue or certain cancers.

ENDRA’s TAEUS technology could be a game-changer for the clinical care cycle of liver [and other] disease—from screening to diagnosis to therapy guidance—especially in markets [like China] where ultrasound is the primary imaging modality.

Jing Gao, M.D.

Deputy President, Dalian University International Institute of Medical Imaging, China
Arrow Down

Case study:
Tissue temperature

Understanding tissue temperature is essential for guiding energy-based surgery, which relies on heat or cold to affect tissues in the treatment of cancer, cardiac arrhythmia and pain management.


The Problem

Today, clinicians typically use printed paper guidelines to estimate how much heat or cold will be deposited into tissues during energy-based surgery. That inaccuracy can lead to improperly administered therapy.

Cluster Electrode Tissue
Treatment Target

2.5 cm exposure, 12 minutes

Single Electrode Tissue
Treatment Target

2.0 cm exposure, 6 minutes

Doctors aren't always sure where the [thermo-ablative] heat is going. They could hit a vessel or another heat-sink in the body and the academic models fall apart and treatment is ineffective.

Jonathan Rubin, M.D.

Head for Ultrasound & Abdominal Interventional Radiology, The University of Michigan

The solution

TAEUS is being developed to enable clinicians to see tissue temperature change in real time on conventional ultrasound, removing the guesswork from this complicated procedure.

Thermo-ablative surgery is just one example of the healthcare challenges ENDRA is tackling. With enhancements to conventional ultrasound, we will plan to revolutionize what clinicians can see and do in real time.

Bringing TAEUS’ improved soft-tissue contrast capabilities to point-of-care ultrasound aligns extremely well with China’s efforts to provide effective, lower-cost health services to its 1.4 billion citizens by shifting care delivery from small urban hospitals to primary-care community clinics.

Jing Gao, M.D.

Deputy President, Dalian University International Institute of Medical Imaging, China
The TAEUS product is not yet approved for commercial sale.